Overview: Reduction in healthcare Associated infections through an innovative, rapid approach for hand disinfection

We are developing a rapid hand disinfection system, based on our proprietary technology, to reduce the number of healthcare associated infections (HAIs). According to a 2011 Centers for Disease Control and Prevention (CDC) survey, 1 in 25 patients in the United States will contract an HAI while in care, with close to 75,000 of these patients dying annually. While CDC figures show that HAIs cost the United States healthcare system upwards of $30 billion dollars annually, there is no figure that can be placed on the physical and emotional burdens incurred by patients and their families.  Our team of engineers, designers, ethnographers, and scientists have worked to understand infection control and the human behaviors associated with hand disinfection, including the limitations of hand-washing and alcohol-based disinfectants.  We have identified the key features needed in a device and have developed and validated test methods to establish efficacy and safety.  We are seeking investors to fund the development of prototypes and enable testing against relevant clinical pathogens, including Clostridium difficile spores.